E
Elizabeth Miller
Researcher at University of Pittsburgh
Publications - 516
Citations - 24139
Elizabeth Miller is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Medicine & Vaccination. The author has an hindex of 68, co-authored 395 publications receiving 21373 citations. Previous affiliations of Elizabeth Miller include Northwestern University & Washington Hospital.
Papers
More filters
Journal ArticleDOI
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study
TL;DR: Around one child in every three was infected with 2009 pandemic H1N1 in the first wave of infection in regions with a high incidence, ten times more than estimated from clinical surveillance.
Journal ArticleDOI
Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association
Brent Taylor,Elizabeth Miller,CPaddy Farrington,Maria-Christina Petropoulos,Isabelle Favot-Mayaud,Jun Li,Pauline Waight +6 more
TL;DR: The authors' analyses do not support a causal association between MMR vaccine and autism, and it is suggested that if such an association occurs, it is so rare that it could not be identified in this large regional sample.
Journal ArticleDOI
Immunization of low density lipoprotein (ldl) receptor-deficient rabbits with homologous malondialdehyde-modified ldl reduces atherogenesis
TL;DR: An important role for the immune system in modulating the atherogenic process is suggested and a novel approach for inhibiting the progression of atherosclerosis is indicated.
Journal ArticleDOI
Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging
TL;DR: It is proposed that the collapse of proteostasis represents an early molecular event of aging that amplifies protein damage in age-associated diseases of protein conformation.
Journal ArticleDOI
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study
TL;DR: Despite much serotype replacement, a substantial reduction in invasive pneumococcal disease in young children can be achieved with PCV7 vaccination, with some indirect benefit in older age groups.